X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Traditional treatment methods typically involve surgery, which may have a risk of scarring or loss of function, treatment with Rhenium-SCT (Rhenium-188) employs a non-invasive superficial application of a paste containing ß-emitting particles directly to the lesion.
Lead Product(s): Rhenium-188
Therapeutic Area: Oncology Product Name: Rhenium-SCT
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: OncoBeta
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement June 23, 2022
Details:
Avion Pharmaceuticals gets exclusive rights to relaunch Cenestin® in the USA. Cenestin® is the only plant-derived mixture of nine conjugated estrogens indicated for treatment of moderate to severe symptoms of vasomotor, and vulvar and vaginal atrophy due to menopause.
Lead Product(s): Conjugated Estrogens
Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Product Name: Cenestin
Highest Development Status: ApprovedProduct Type: Small molecule
Recipient: Aspen Pharmacare Holdings
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership November 12, 2020
Details:
Gloperba (colchicine oral solution) inhibits the Beta tubulin polymerisation, which is indicated for the prophylaxis of gout flares in adults patients.
Lead Product(s): Colchicine
Therapeutic Area: Rheumatology Product Name: Gloperba
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable February 27, 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
